Order Article Reprints

Lingl JP, Wunderlich A, Goerke S, Paech D, Ladd ME, Liebig P, Pala A, Kim SY, Braun M, Schmitz BL, et al. The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T. Diagnostics. 2022; 12(2):490. https://doi.org/10.3390/diagnostics12020490

Lingl, Julia P., Arthur Wunderlich, Steffen Goerke, Daniel Paech, Mark E. Ladd, Patrick Liebig, Andrej Pala, Soung Yung Kim, Michael Braun, Bernd L. Schmitz, and et al. 2022. "The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T" Diagnostics 12, no. 2: 490. https://doi.org/10.3390/diagnostics12020490

Lingl, J. P., Wunderlich, A., Goerke, S., Paech, D., Ladd, M. E., Liebig, P., Pala, A., Kim, S. Y., Braun, M., Schmitz, B. L., Beer, M., & Rosskopf, J. (2022). The Value of APTw CEST MRI in Routine Clinical Assessment of Human Brain Tumor Patients at 3T. Diagnostics, 12(2), 490. https://doi.org/10.3390/diagnostics12020490